- Reaction score
- 292
I wonder if there were issues with any patents from the original preclinical publication they had doneI just don't understand why
maybe it's up to the existing partners. The contracts were signed years ago. maybe he doesn't want to renegotiate everything.
there is lots more than what they have told us. They said they achieved 80% turnover rate in cell to HF formation but only showed figures of 1 or 2 hairs cycling in Mice
then all of a sudden they said they did safety tests in humans. Plus they have had so much success in regenerative research with teeth and salivary glands. There is a reason they haven’t received any money yet
Last edited: